Annual Report 2020

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2020 84 The United Laboratories International Holdings Limited Annual Report 2020 5. REVENUE AND SEGMENT INFORMATION (Continued) Segment information (Continued) (b) Other segment information Amounts included in the measurement of segment profit or loss: For the year ended 31 December 2020 Intermediate Bulk Finished products medicine products Unallocated Consolidated RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Amortisation of intangible assets 1,840 – 10,872 – 12,712 Depreciation of right-of-use assets 4,975 2,572 759 – 8,306 Depreciation of property, plant and equipment 455,141 80,141 49,639 8,526 593,447 Net (gain) loss on disposal of property, plant and equipment (4,591) (448) 183 (38,679) (43,535) Impairment losses (reversed) recognised (4,914) (933) 2,377 69,382 65,912